Schneider Capital Management Has Cut Its Keycorp (KEY) Holding; CRONOS GROUP ORDINARY SHARES (PRMCF) Shorts Down By 13.39%

March 22, 2018 - By Nellie Frank

Schneider Capital Management Corp decreased Keycorp (KEY) stake by 18.46% reported in 2017Q3 SEC filing. Schneider Capital Management Corp sold 282,412 shares as Keycorp (KEY)’s stock declined 6.49%. The Schneider Capital Management Corp holds 1.25M shares with $23.48M value, down from 1.53M last quarter. Keycorp now has $21.69B valuation. The stock decreased 2.48% or $0.52 during the last trading session, reaching $20.45. About 3.54M shares traded. KeyCorp (NYSE:KEY) has risen 43.10% since March 22, 2017 and is uptrending. It has outperformed by 26.40% the S&P500.

CRONOS GROUP INC ORDINARY SHARES (OTCMKTS:PRMCF) had a decrease of 13.39% in short interest. PRMCF’s SI was 1.52M shares in March as released by FINRA. Its down 13.39% from 1.75 million shares previously. With 1.61M avg volume, 1 days are for CRONOS GROUP INC ORDINARY SHARES (OTCMKTS:PRMCF)’s short sellers to cover PRMCF’s short positions. The SI to CRONOS GROUP INC ORDINARY SHARES’s float is 1.37%. It closed at $7.7602 lastly. It is down 0.00% since March 22, 2017 and is . It has underperformed by 16.70% the S&P500.

Investors sentiment decreased to 0.96 in 2017 Q3. Its down 0.14, from 1.1 in 2017Q2. It is negative, as 46 investors sold KEY shares while 196 reduced holdings. 67 funds opened positions while 200 raised stakes. 841.58 million shares or 1.81% less from 857.12 million shares in 2017Q2 were reported. Hanson And Doremus Inv reported 74 shares. Janney Montgomery Scott Ltd holds 93,963 shares or 0.02% of its portfolio. Colony Grp Inc Ltd Liability Co stated it has 0.02% in KeyCorp (NYSE:KEY). Moreover, Kbc Nv has 0.09% invested in KeyCorp (NYSE:KEY) for 526,871 shares. Northpointe Ltd Llc accumulated 161,882 shares. Shine Investment Advisory Svcs stated it has 1,905 shares or 0.02% of all its holdings. Savings Bank holds 0.01% or 32,729 shares in its portfolio. Virginia-based Quantitative Investment Mngmt Limited Liability Corp has invested 0.06% in KeyCorp (NYSE:KEY). Bp Public Limited Liability Com invested in 122,000 shares or 0.08% of the stock. Picton Mahoney Asset Mngmt invested in 1.26% or 891,325 shares. The Illinois-based Magnetar Financial Ltd Liability has invested 0.02% in KeyCorp (NYSE:KEY). Gotham Asset Mngmt Lc invested in 0.02% or 55,903 shares. Bouchey Grp Inc Ltd holds 0.14% or 24,265 shares in its portfolio. Cetera Advisor Ntwk Limited Liability owns 12,223 shares for 0.01% of their portfolio. Fagan Associates Incorporated has invested 0.11% of its portfolio in KeyCorp (NYSE:KEY).

Schneider Capital Management Corp increased Intevac Inc (NASDAQ:IVAC) stake by 67,826 shares to 361,686 valued at $3.06 million in 2017Q3. It also upped Veeco Instruments Inc (NASDAQ:VECO) stake by 313,712 shares and now owns 488,137 shares. Qep Resources Inc. (NYSE:QEP) was raised too.

Analysts await KeyCorp (NYSE:KEY) to report earnings on April, 19 before the open. They expect $0.39 EPS, up 21.88% or $0.07 from last year’s $0.32 per share. KEY’s profit will be $413.67M for 13.11 P/E if the $0.39 EPS becomes a reality. After $0.36 actual EPS reported by KeyCorp for the previous quarter, Wall Street now forecasts 8.33% EPS growth.

Since October 24, 2017, it had 1 insider buy, and 5 insider sales for $2.86 million activity. Paine Andrew J III sold 46,854 shares worth $869,610. 2,758 KeyCorp (NYSE:KEY) shares with value of $51,122 were sold by Harris Paul N. The insider Buffie Craig A sold 11,819 shares worth $250,639. 25,000 shares valued at $527,750 were sold by DeAngelis Robert A on Wednesday, February 21. $9,998 worth of stock was bought by Midkiff Mark W on Monday, January 29. Gorman Christopher M. had sold 56,038 shares worth $1.18 million.

Among 34 analysts covering Keycorp (NYSE:KEY), 21 have Buy rating, 2 Sell and 11 Hold. Therefore 62% are positive. Keycorp had 108 analyst reports since July 20, 2015 according to SRatingsIntel. The stock has “Market Perform” rating by KBW on Wednesday, August 12. On Tuesday, September 5 the stock rating was maintained by Robert W. Baird with “Hold”. As per Thursday, July 20, the company rating was upgraded by DA Davidson. Morgan Stanley maintained the stock with “Overweight” rating in Thursday, December 14 report. As per Monday, July 10, the company rating was upgraded by UBS. The firm has “Hold” rating given on Monday, April 24 by Oppenheimer. On Monday, April 24 the stock rating was maintained by Nomura with “Buy”. The firm earned “Buy” rating on Thursday, October 19 by Piper Jaffray. On Wednesday, September 9 the stock rating was initiated by BMO Capital Markets with “Outperform”. Macquarie Research maintained it with “Outperform” rating and $14.50 target in Monday, November 2 report.

Cronos Group, formerly known as PharmaCan Capital Corp., is a principal investment firm. The company has market cap of $1.24 billion. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to CanadaÂ’s Marihuana for Medical Purposes Regulations . It has a 970.02 P/E ratio. The firm typically invests in companies based in Canada.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: